Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/8/2017
SIETES contiene 91969 citas

 
 
 1 a 20 de 92 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]
2. Cita con resumen
Fralick M, Avorn J, Kesselheim AS. The price of crossing the border for medications. N Engl J Med 2017;377:311-3. [Ref.ID 101925]
3. Cita con resumen
Anónimo. Global spending on prescription drugs to hit $1.5 trillion by 2021. DIA Daily 2016:1. [Ref.ID 100994]
5. Cita con resumen
Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016;316:858-71. [Ref.ID 100589]
6. Cita con resumen
Anónimo. CMS paid $121 billion for drugs in 2014, data show. DIA Daily 2016:1. [Ref.ID 100587]
7. Cita con resumen
Bradford AC, Bradford D. Medical marijuana laws reduce prescription medication use In Medicare Part D. Health Affairs 2016;37:julio. [Ref.ID 100483]
8. Cita con resumen
Johansen ME, Richardson C. Estimation of potential savings through therapeutic substitution. JAMA Intern Med 2016;176:769-75. [Ref.ID 100398]
9. Cita con resumen
Hua X, Carvalho N, Tew M, Huang ES, Herman WH, Clarke P. Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013. JAMA 2016;315:1400-2. [Ref.ID 100201]
10. Cita con resumen
McCarthy M. US Senate committee launches investigation into drug pricing. BMJ 2015;351:h5989. [Ref.ID 99683]
11. Cita con resumen
12.Enlace a cita original Cita con resumen
Herper M. The top drug launches of all time. Forbes 2015:29 de julio. [Ref.ID 99456]
13. Cita con resumen
Wilensky G. A new focus on prescription drug spending. JAMA 2015;314:440-1. [Ref.ID 99400]
14. Cita con resumen
Sarpatwari A, Avorn J, Kesselheim AS. Progress and hurdles for follow-on biologics. N Engl J Med 2015;372:2380-2. [Ref.ID 99297]
15. Cita con resumen
Anónimo. MS finds spending on cancer medications rose 10.3 percent in 2014 to $100 billion. DIA Daily 2015:5 de mayo. [Ref.ID 99029]
16. Cita con resumen
Anónimo. Report: 12% drug spending increase in 2014 driven largely by hepatitis C treatments. DIA Daily 2015:10 de marzo. [Ref.ID 98837]
17. Cita con resumen
Martín Matas M. La factura farmacèutica. Ara 2014:42-3. [Ref.ID 97909]
20. Cita con resumen
Donohue JM, Morden NE, Gellad WF, Bynum JP, Zhou W, Hanlon JT, Skinner J. Sources of regional variation in Medicare Part D drug spending. N Engl J Med 2012;366:530-8. [Ref.ID 92341]
Seleccionar todas
 
 1 a 20 de 92 siguiente >>